Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Holders of 5% or more of TNXP

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tonix Pharmaceuticals Holding Corp., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of TNXP
HolderLatest formStakeChangeFirst filedLatest filingFiling
Point72 Asset Management, L.P.13G/A6.90%1.10M shares−2.30 ppfrom 9.20%Dec 31, 20252 filingsMay 15, 2026SEC
BlackRock, Inc.13G/A6.70%854.6K shares−1.10 ppfrom 7.80%Jul 17, 20253 filingsJan 21, 2026SEC
Millennium Management LLC13G5.60%890.4K sharesNewJun 15, 20261 filingJun 15, 2026SEC
AQR Capital Management LLC13G5.54%882.6K sharesNewAug 13, 20261 filingAug 13, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

19 Schedule 13D and 13G filings on Tonix Pharmaceuticals Holding Corp., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TNXP
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20268:36 AM ETSirenia Capital Management LPand 1 other13G/A4.90%814.8K shares−3.90 ppfrom 8.80%Below 5%Jun 30, 2026SEC
Aug 13, 20269:17 AM ETAQR Capital Management LLCand 1 other13G5.54%882.6K sharesNewJun 30, 2026SEC
Jun 15, 20265:44 PM ETMillennium Management LLCand 2 others13G5.60%890.4K sharesNewJun 9, 2026SEC
May 15, 20264:22 PM ETPoint72 Asset Management, L.P.and 2 others13G/A6.90%1.10M shares−2.30 ppfrom 9.20%Mar 31, 2026SEC
May 15, 20268:06 AM ETSirenia Capital Management LPand 1 other13G8.80%1.30M sharesNewMar 31, 2026SEC
Mar 27, 20261:32 PM ETVanguard Group Inc13G/A0.00%0 shares−5.02 ppfrom 5.02%Below 5%Mar 13, 2026SEC
Jan 30, 20262:45 PM ETVanguard Group Inc13G/A5.02%673.6K shares−1.33 ppfrom 6.35%Dec 31, 2025SEC
Jan 21, 202612:30 PM ETBlackRock, Inc.13G/A6.70%854.6K shares−1.10 ppfrom 7.80%Dec 31, 2025SEC
Dec 31, 20254:10 PM ETPoint72 Asset Management, L.P.and 2 others13G9.20%1.24M sharesNewDec 29, 2025SEC
Oct 31, 202511:31 AM ETVanguard Group Inc13G6.35%557.0K sharesNewSep 30, 2025SEC
Oct 17, 20256:41 PM ETBlackRock, Inc.13G/A7.80%680.0K shares+2.10 ppfrom 5.70%Sep 30, 2025SEC
Jul 17, 20258:12 PM ETBlackRock, Inc.13G5.70%420.4K sharesNewJun 30, 2025SEC
Feb 14, 20255:05 PM ETL1 Capital Global Opportunities Master Fund, Ltd.13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Jan 3, 20252:56 PM ETSabby Management, LLCand 2 others13G/A0.70%1.31M shares–Below 5%Dec 31, 2024SEC
Feb 16, 2021CVI Investments, Inc.13G/AOld format–––SEC
Feb 16, 2021Armistice Capital, LLC13G/AOld format–––SEC
Feb 11, 2021Altium Capital Management LP13G/AOld format–––SEC
Feb 11, 2021Renaissance Technologies LLC13G/AOld format–––SEC
Jan 5, 2021Sabby Management, LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Tonix Pharmaceuticals Holding Corp. shares.

No Form 144 notices for Tonix Pharmaceuticals Holding Corp. are on file.